ATP4A / Potassium-transporting ATPase alpha chain 1 · IHC design guide

Design Immunohistochemistry for ATP4A

Plan ATP4A staining in paraffin sections using the IHC-validated antibody (datasheet A08198-1). Interpret cytoplasmic staining in gastric parietal cells (HPA tissue IHC) alongside the protein’s apical canalicular membrane localisation (UniProt).

Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
Immunohistochemistry protocol sheet for ATP4A (IHC for ATP4A): expected localisation Cytoplasmic in gastric parietal cells (HPA tissue IHC); apical canalicular membrane (UniProt), antibody A08198-1, validated IHC image, and IHC protocol steps
Printable ATP4A IHC protocol sheet — expected localisation Cytoplasmic in gastric parietal cells (HPA tissue IHC); apical canalicular membrane (UniProt), antibody A08198-1, controls and protocol steps. Open the full ATP4A IHC guide →

ATP4A Immunohistochemistry Experimental Design Guide

Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before staining
Expected localisation Cytoplasmic in gastric parietal cells (HPA tissue IHC); apical canalicular membrane (UniProt)
Staining pattern Cytoplasmic staining in gastric parietal cells (HPA tissue IHC)
Antigen retrieval EDTA pH 8.0 HIER, heat-mediated (datasheet A08198-1)
Positive control ⓘ Stomach+1 more · see all
Negative control ⓘ Adipose tissue+4 more · see all
Important caveats
Reasons your staining may differ from the expected pattern.
Fixation Keep fixation consistent across sections (standard IHC practice; not target-specific); Matched tissue-IHC evidence does not establish the fixation claim. Validate the specimen-specific method before use. (selected-SKU IHC image A08198-1)
Caveat Late spermatids in testis also stain strongly (HPA tissue IHC)
Regulation Expression regulation not specified (UniProt)
Isoform / epitope One chain; no isoforms annotated; epitope side matters (UniProt)
Section 1

Recommended ATP4A IHC & IF Protocols

Compare the catalog antibody’s IHC protocol (datasheet A08198-1) with one published ATP4A paraffin section protocol (PMC8874512).

Recommended immunohistochemistry (IHC-P) protocol parameters
SampleParaffin-embedded rat stomach tissue; fixative not specified (datasheet A08198-1)
FixationImage fixative and duration unreported (datasheet A08198-1); verify before use.
Sectioning4–5 µm sections on charged slides (standard)
DeparaffinisationXylene, graded ethanol series to water (standard)
Antigen retrievalHeat retrieval: EDTA pH 8.0 (datasheet A08198-1); 20 min, 95–100 °C (standard)
Peroxidase block3% H2O2, 10 min, room temperature (standard)
Blocking10% goat serum (datasheet A08198-1)
Primary antibodyRabbit anti-ATP4A, 2 μg/ml (datasheet A08198-1)
Primary incubationOvernight at 4 °C (datasheet A08198-1)
DetectionHRP-conjugated secondary, DAB chromogen (datasheet A08198-1)
CounterstainHematoxylin, blue, dehydrate and mount (standard)
Expected resultATP4A-positive staining in glandular cells of stomach (HPA tissue IHC: High). HPA tissue profile: Cytoplasmic expression in gastric parietal cells. No signal in the no-primary control.
💡Decision noteFor the catalog antibody, start with heat-mediated EDTA retrieval at pH 8.0 (datasheet A08198-1); the published protocol used high-temperature retrieval at pH 9 (PMC8874512).
Section 2

What Is the Expected ATP4A Staining Pattern?

ATP4A is a ten-pass membrane protein localized to the apical canalicular membrane of gastric parietal cells (UniProt P20648 topology and localization). In tissue IHC, expect staining in gastric parietal cells; HPA describes the visible pattern as cytoplasmic and rates its tissue profile Enhanced for consistency with RNA data (HPA: tissue IHC). Interpret an apical pattern alongside that reported cytoplasmic appearance, rather than requiring a sharply outlined membrane in every cell.

What am I looking at on my slide?
Strong staining in a subset of stomach glandular cells, with cytoplasmic or apical canalicular emphasis.This fits the reported high stomach glandular-cell staining and cytoplasmic parietal-cell profile (HPA: stomach IHC), alongside the apical canalicular location (UniProt P20648 localization). Identify the cells by tissue morphology before scoring.
Predominantly nuclear staining in the cells being scored as positive.A nuclear-dominant result does not match the reported cytoplasmic tissue pattern (HPA: tissue IHC) or apical membrane location (UniProt P20648 localization). Treat it as suspect until the staining and controls are reviewed.
Staining across many unrelated cell types, especially in a tissue listed as negative.Broad staining is inconsistent with the restricted gastric pattern (HPA: tissue IHC). In a listed negative population, such as bronchial respiratory epithelium (HPA: bronchus, not detected), consider nonspecific binding or endogenous detection activity.
Diffuse color across the section, obscuring cell boundaries and gland structure.This prevents a reliable call on the reported parietal-cell pattern (HPA: tissue IHC). General IHC practice is to compare a negative control and inspect background before changing the interpretation of weak staining.
No convincing stain in morphologically identified gastric parietal cells.A negative result conflicts with the expected positive tissue pattern (HPA: stomach, High; UniProt P20648 tissue specificity). First check that parietal cells are present, then assess the IHC workflow and antibody performance.
💡Expected ATP4A appearanceCall positive when morphologically identified gastric parietal cells show clear, relatively strong cytoplasmic staining, potentially emphasizing the apical canalicular membrane (HPA: stomach, High and cytoplasmic profile; UniProt P20648 localization); nuclear-only or widespread unrelated-cell staining is suspect against those reference patterns.
How each factor affects the staining
Compartment and cell identityATP4A is assigned to the parietal-cell apical canalicular membrane (UniProt P20648 localization), while HPA describes cytoplasmic staining in those cells (HPA: tissue IHC). Use both references when judging a chromogenic section.
Tissue choice for controlsStomach glandular cells are High (HPA: stomach); bronchial respiratory epithelial cells and adipose-tissue adipocytes are Not detected (HPA: bronchus; HPA: adipose tissue). Verify the relevant cell population is present in each control.
Positive staining outside stomachElongated or late spermatids are also listed as High (HPA: testis). A testis signal therefore cannot be dismissed solely because it lies outside the gastric parietal-cell setting; check cell identity and pattern.
Antibody validation scopeBoth HPA039154 and HPA076684 have Enhanced IHC status (HPA: antibody validation). This supports comparison of tissue staining, but does not establish a dilution, retrieval condition, or performance for an unlisted assay.
Topology and epitope accessATP4A has ten transmembrane segments with cytoplasmic and lumenal loops (UniProt P20648 topology). The supplied records do not place either antibody's epitope, so topology alone cannot justify a target-specific retrieval or permeabilisation setting.
Why is my staining missing, weak or wrong?
SituationLikely causeNext action
Stomach section is negative despite visible parietal cells.The result conflicts with High stomach staining (HPA: stomach) but does not identify which IHC step failed.In general IHC practice, confirm the positive control, primary antibody application, retrieval, and detection reagents before calling the tissue ATP4A-negative.
Stain appears chiefly nuclear.That compartment conflicts with the cytoplasmic tissue profile (HPA: tissue IHC) and apical canalicular location (UniProt P20648 localization).Review morphology and negative controls; in general IHC practice, check primary-antibody specificity and detection background before scoring it as ATP4A.
Bronchial respiratory epithelium stains strongly.That population is listed Not detected (HPA: bronchus); nonspecific binding or endogenous detection activity may explain unexpected color.Compare controls and inspect detection background; adjust blocking or detection conditions as indicated by those controls (general IHC practice).
Stomach stain is widespread and glandular cells cannot be distinguished.Diffuse background obscures the expected cell-specific profile (HPA: stomach IHC). The image alone cannot establish whether target signal is present.Use general IHC controls to check background from primary and detection steps, then optimize washing or antibody concentration if warranted.
Testis shows staining in elongated or late spermatids.That cell population is listed High (HPA: testis), despite the gastric parietal-cell tissue-specificity statement (UniProt P20648).Check that staining follows the named spermatid population (HPA: testis); avoid labeling the result cross-reactive solely because the tissue is testis.
Can IF/ICC reproduce this section's pattern?HPA summarizes ATP4A as Membrane but provides no ICC-IF cell-line images or main-location assignment (HPA: subcellular).Treat IF/ICC localization as unconfirmed here (HPA: subcellular). Consult the separate IF/ICC guide for assay design; this IHC interpretation supplies no IF protocol.

Sample controls for ATP4A IHC & IF

🧪Run stomach first: glandular cells should stain (HPA: High in stomach glandular cells; UniProt P20648: expression in gastric parietal cells). Use adrenal gland as the negative tissue (HPA: Not detected in adrenal glandular cells); neighboring nonparietal cells on the stomach slide should lack specific staining (UniProt P20648: parietal-cell expression).
Positive control tissue: Stomach (Glandular cells, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA carries no ICC-IF cell line for ATP4A; derive a cell-line control from the positive tissue's cell type (Glandular cells) and confirm it by RNA or western blot first.
Technical controls: Include a no-primary, secondary-only slide, a host- and class-matched rabbit IgG isotype control, and ATP4A knockout tissue if available (standard IHC controls; selected A08198-1 caption: rabbit primary antibody). Quench endogenous peroxidase in stomach sections to limit background with HRP/DAB detection (standard IHC practice; selected A08198-1 caption: HRP/DAB).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported in the supplied evidence, and the selected A08198-1 tissue-IHC caption does not report a fixative. The paraffin-section example uses heat retrieval in EDTA at pH 8.0 before staining rat stomach; this documents one working condition, not a requirement for every specimen (selected A08198-1 caption). Frozen-section and IF performance are unreported, so neither can be judged easier than the documented paraffin IHC approach; endogenous peroxidase is a potential stomach-section artefact with HRP/DAB detection (HPA: no cell lines with ICC-IF images; selected A08198-1 caption: HRP/DAB; standard IHC practice).

HPA tissue IHC evidence for ATP4A

Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — High consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Stomach Glandular cells High Protein (IHC) HPA →
Testis Elongated or late spermatids High Protein (IHC) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue Adipocytes Not detected Protein (IHC) HPA →
Adrenal gland Glandular cells Not detected Protein (IHC) HPA →
Appendix Glandular cells Not detected Protein (IHC) HPA →
Bone marrow Hematopoietic cells Not detected Protein (IHC) HPA →
Breast Adipocytes Not detected Protein (IHC) HPA →
Section 3

Advanced ATP4A IHC Tips

ATP4A staining should be assessed in the context of gastric parietal cells and their apical canalicular membranes (UniProt P20648).

What retrieval should I use if ATP4A staining is weak in paraffin sections?
Use heat-mediated antigen retrieval in EDTA at pH 8.0 before applying the catalog antibody (datasheet A08198-1). The selected paraffin-section example used this retrieval on rat stomach, followed by 2 μg/ml primary antibody overnight at 4°C (caption A08198-1). If staining remains weak, compare retrieval heating and cooling conditions on adjacent sections while keeping antibody concentration and detection constant (standard IHC practice). Include a stomach section with identifiable parietal cells when comparing conditions, because ATP4A protein is expressed in those cells (UniProt P20648). Check tissue preservation and section adhesion before increasing retrieval intensity, which can damage morphology (standard IHC practice).
Could fixation explain weak or uneven ATP4A staining?
The selected paraffin-section caption does not identify its fixative, so ATP4A-specific fixation sensitivity is unknown (caption A08198-1). Record the fixative, fixation duration, tissue thickness and processing history for each specimen before comparing staining runs (standard IHC practice). Compare similarly processed stomach sections using the stated EDTA pH 8.0 retrieval and 2 μg/ml primary antibody conditions (caption A08198-1). If signal differs, inspect morphology and repeat staining on adjacent sections to distinguish processing variation from uneven reagent coverage (standard IHC practice). Do not attribute a staining difference specifically to ATP4A epitope damage without a controlled fixation comparison (standard IHC practice).
Should ATP4A appear cytoplasmic or along the parietal-cell membrane?
Evaluate staining in gastric parietal cells, where ATP4A protein is reported, and inspect the apical canalicular region at high magnification (UniProt P20648). ATP4A localizes to the apical canalicular membrane, while the tissue IHC profile describes cytoplasmic expression in gastric parietal cells (UniProt P20648 localisation; HPA tissue IHC). Resolve that difference by examining whether granular or cytoplasmic-looking signal follows canalicular structures within intact parietal cells (UniProt P20648 localisation; HPA tissue IHC). Use a counterstain and adjacent section to identify cell boundaries and gland architecture before scoring ambiguous signal (standard IHC practice). Diffuse staining across unrelated cells warrants review of background and detection controls (standard IHC practice).
How should epitope location affect ATP4A IHC troubleshooting?
ATP4A has no isoforms annotated in the supplied record, so an isoform-specific staining explanation is unsupported (UniProt P20648 isoforms). Its 10 transmembrane segments separate cytoplasmic and lumenal regions, but the catalog antibody's epitope is unspecified here (UniProt P20648 topology; caption A08198-1). Check the antibody's epitope documentation before interpreting a negative section as evidence that a particular membrane-facing region is absent (standard IHC practice). For the documented paraffin-section workflow, start with EDTA pH 8.0 retrieval rather than choosing conditions from an assumed epitope position (datasheet A08198-1). If comparing antibodies, assess whether each stains the expected parietal-cell population under its own validated conditions (UniProt P20648 tissue specificity; standard IHC practice).
How can I assess ATP4A by multiplex IF alongside a parietal-cell marker?
Treat IF as a separately optimized application; the supplied catalog example documents chromogenic staining of a paraffin section (caption A08198-1). Multiplex ATP4A with ATP4B as a parietal-cell-associated marker, recognizing that the proteins form the gastric pump together (UniProt P20648 subunit and tissue specificity). Choose spectrally separated fluorophores and consider a far-red channel when tissue autofluorescence obscures shorter-wavelength signal (standard IF practice). Determine whether the antibody recognizes a cytoplasmic or lumenal region before selecting permeabilisation conditions, because ATP4A spans the membrane 10 times and its antibody epitope is unspecified here (UniProt P20648 topology; caption A08198-1). Include single-label and no-primary controls to assess bleed-through and background (standard IF practice).
What should I check when DAB stains cells outside gastric glands?
First compare signal with a no-primary control to identify staining contributed by the detection system (standard IHC practice). The selected example used 10% goat serum blocking, a peroxidase-conjugated secondary antibody and DAB detection in rat stomach (caption A08198-1). Check that a general peroxidase-blocking step is effective, and shorten DAB development if the control section develops diffuse colour (standard IHC practice). Inspect washing, tissue folds and section edges before changing primary concentration, because pooled reagent can create local background (standard IHC practice). Use stomach parietal cells as the expected comparison population; HPA also reports high staining in testis spermatids, so staining outside stomach is not automatically artefactual (UniProt P20648 tissue specificity; HPA tissue IHC).
How should I quantify ATP4A staining across stomach sections? ⚠ ANSWER MARKED FOR VERIFICATION
Define the gastric gland region and identify parietal cells before scoring, since ATP4A protein is reported in that cell type (UniProt P20648 tissue specificity). Report the percentage of positive parietal cells and, when intensity matters, an H-score from 0–300 using intensity grades 0–3 (standard IHC scoring practice). Normalize cell counts to the number of evaluable parietal cells, or report positive-cell density per mm² of evaluable gland area (standard IHC quantification practice). Apply one prespecified positivity threshold and comparable imaging and DAB development conditions across sections (standard IHC practice). Exclude folds, damaged tissue and section edges using the same rules for every specimen (standard IHC practice).
How do I distinguish genuine ATP4A staining from an artefact?
A convincing pattern involves gastric parietal cells and is compatible with their apical canalicular membranes (UniProt P20648 tissue specificity and localisation). Apparent cytoplasmic staining can still merit examination, because the tissue IHC profile describes cytoplasmic expression in gastric parietal cells (HPA tissue IHC). Compare intact gland architecture with section edges and necrotic or damaged areas; staining restricted to compromised areas is suspect (standard IHC practice). Review a no-primary control and peroxidase blocking if DAB appears broadly in unexpected cells, since endogenous enzyme or detection background can mimic a positive result (standard IHC practice). Document both the stained cell type and subcellular pattern before assigning a positive score (standard IHC practice).
Boster reagents

Best ATP4A / Potassium-transporting ATPase alpha chain 1 IHC Antibodies

The catalog antibody has real IHC data from rat and human paraffin-embedded stomach sections, including human stomach cancer tissue; no IF image is provided (catalog image captions).

Real IHC data IHC analysis of ATP4A using anti-ATP4A antibody (A08198-1). ATP4A was detected in a paraffin-embedded section of rat stomach tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 μg/ml rabbit anti-ATP4A Antibody (A08198-1) overnight at 4°C. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using HRP Conjugated Rabbit IgG Super Vision Assay Kit (Catalog # SV0002) with DAB as the chromogen.
Anti-ATP4A Antibody ®
Cat # A08198-1

A08198-1 is listed for IHC and reacts with human, mouse and rat (catalog applications and reactivity). Its images show staining in paraffin-embedded rat stomach, human stomach and human stomach cancer sections (A08198-1 image captions).

Which to pick: Choose A08198-1 for tissue IHC: its captions document paraffin-embedded sections with EDTA retrieval at pH 8.0 and antibody at 2 μg/ml; the fixative is unreported (A08198-1 image captions). No SKU in the payload is listed for IF/ICC, so there is no documented IF/ICC choice here (catalog applications and images). A08198-1 is listed as reactive with human, mouse and rat, although its IHC images show only human and rat samples; its host is rabbit and clonality is unreported (catalog reactivity, image captions and host field).

Each figure is that product's own IHC / IF validation image from its datasheet.

References

  1. UniProt Consortium. UniProt entry P20648 (ATP4A_HUMAN, Potassium-transporting ATPase alpha chain 1).
  2. Human Protein Atlas. ATP4A tissue IHC expression (reliability: Enhanced).
  3. Human Protein Atlas. ATP4A subcellular location (ICC-IF): Membrane.
  4. Human Protein Atlas. ATP4A antibody validation summary (2 antibodies).
  5. Crosstalk between Acidosis and Iron Metabolism: Data from In Vivo Studies. Metabolites 2022 — PMC8874512.
  6. Weipiling ameliorates gastric precancerous lesions in Atp4a(-/-) mice. BMC complementary and alternative medicine 2019 — PMC6862855.
  7. Taurine suppresses gastric intestinal metaplasia in patient-derived organoids and Atp4a (-/-) mice. World journal of gastrointestinal oncology 2026 — PMC12898405.
  8. Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology. Neurology(R) neuroimmunology & neuroinflammation 2024 — PMC11078148.
  9. PubMed PMID:2160952 — UniProt-cited evidence.
  10. PubMed PMID:2176086 — UniProt-cited evidence.
  11. PubMed PMID:15057824 — UniProt-cited evidence.